GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference
22 December 2017 - 8:03AM
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, today
announced that President and Chief Executive Officer, Hany
Massarany, will present at the J.P. Morgan 36th Annual Healthcare
Conference in San Francisco, CA.
Mr. Massarany is scheduled to present on Wednesday,
January 10 at 3:30pm Pacific Time. Interested parties may access a
live and archived webcast of the event at ir.genmarkdx.com.
About GenMark DiagnosticsGenMark
Diagnostics (NASDAQ:GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care,
improve key quality metrics, and reduce the total cost-of-care.
Utilizing GenMark's proprietary eSensor® detection technology,
GenMark's eSensor XT-8® and ePlex® systems are designed to support
a broad range of molecular diagnostic tests with compact,
easy-to-use workstations and self-contained, disposable test
cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is
designed to optimize laboratory efficiency and address a broad
range of infectious disease testing needs, including respiratory,
bloodstream, and gastrointestinal infections. For more
information, visit www.genmarkdx.com.
Investor Relations ContactLynn
Pieper Lewis or Leigh Salvo
(415) 937-5404
ir@genmarkdx.com
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2024 to May 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about GenMark Diagnostics Inc (NASDAQ): 0 recent articles
More News Articles